Biolase Technology Inc.
- Share via
The San Clemente manufacturer of dental, cosmetic, aesthetic and surgical products narrowed its losses in the third quarter. The company said it lost $873,479, or 5 cents a share, compared with a year-earlier net loss of $6.7 million, or 41 cents a share, which included a noncash write-off of $5.1 million in costs related to the acquisition of certain technology assets. Sales climbed to $2 million from $87,686.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
